Insider Stock Trading History of Stelzer Laurie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Stelzer Laurie since year 2005. The trader's CIK number is 1644348. At the time of this reporting, Stelzer Laurie is the SVP, Chief Financial Officer of Halozyme Therapeutics Inc . (stock ticker symbol HTI). See this page for all insider trading activities at Halozyme Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Stelzer Laurie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-15 HALO Halozyme Therapeutics Inc Option Ex 6,875 .00 0
2017-02-03 HALO Halozyme Therapeutics Inc Option Ex 23,120 .00 0
2016-06-15 HALO Halozyme Therapeutics Inc Option Ex 6,875 .00 0
2015-08-20 HALO Halozyme Therapeutics Inc Buy 10,000 17.24 172,380

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stelzer Laurie (SVP, Chief Financial Officer of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.